SGRY
$15.12
$-0.07 (-0.46%)-0.46%
OpenLoading chart...
IndexN/A
Market Cap1.98B
Enterprise Value5.75B
Income$-0.04B
Sales$0.78B
EmployeesN/A
P/E38.76
P/S0.59
P/B1.15
P/C10.05
EV/EBITDA10.17
EV/SalesN/A
EPS (ttm)0.39
EarningsN/A
Gross Margin23.12%
Oper. Margin11.77%
Profit Margin-2.35%
Volume0.62M
Shs Outstand0.13B
Change-0.48%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.11B | $2.74B | $2.54B | $2.23B | $1.86B | $1.83B | $1.77B | $1.34B |
| Cost of Revenue | $2.37B | $2.10B | $1.96B | $1.73B | $1.48B | $1.41B | $1.36B | $1.01B |
| Gross Profit | $745.60M | $647.50M | $574.90M | $491.40M | $379.80M | $423.80M | $410.02M | $327.42M |
| Gross Margin | 23.94% | 23.60% | 22.64% | 22.08% | 20.42% | 23.14% | 23.15% | 24.41% |
| Operating Expenses | $396.80M | $319.50M | $229.70M | $189.20M | $196.80M | $187.90M | $332.19M | $169.19M |
| Operating Income | $348.80M | $328.00M | $345.20M | $302.20M | $183.00M | $235.90M | $77.84M | $158.23M |
| Operating Margin | 11.20% | 11.96% | 13.59% | 13.58% | 9.84% | 12.88% | 4.39% | 11.80% |
| Net Income | $-168.10M | $-11.90M | $-54.60M | $-70.90M | $-116.10M | $-74.80M | $-205.71M | $-52.98M |
| Net Margin | -5.40% | -0.43% | -2.15% | -3.19% | -6.24% | -4.08% | -11.61% | -3.95% |
| EPS (Basic) | $-1.33 | $-0.09 | $-0.59 | $-1.12 | $-3.19 | $0.95 | $-4.28 | $-1.09 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $7.89B | $6.88B | $6.68B | $6.12B | $5.41B | $5.02B | $4.68B | $4.62B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $4.25B | $3.51B | $3.40B | $3.82B | $3.79B | $3.32B | $4.68B | $4.62B |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $1.79B | $1.99B | $2.00B | $1.09B | $550.10M | $691.80M | $404.64M | $654.73M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $1.79B | $1.99B | $2.00B | $1.09B | $550.10M | $691.80M | $404.64M | $654.73M |
| Total Liabilities & Stockholders Equity | $7.89B | $6.88B | $6.68B | $6.12B | $5.41B | $5.02B | $4.68B | $4.62B |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-168.10M | $-11.90M | $-54.60M | $-70.90M | $-116.10M | $-74.80M | $-205.71M | $-52.98M |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $300.10M | $293.80M | $158.80M | $87.10M | $246.90M | $129.50M | $144.60M | $120.94M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call DetailsGlobeNewswire Inc. Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 MillionThe Motley Fool Ambulatory Surgical Centers Market to Reach Over US$ 142.6 Billion by 2033 Driven by Rising Outpatient Surgeries, Favorable Reimbursement, and Cost-Efficient Care Models | Astute AnalyticaGlobeNewswire Inc. Surgery Partners, Inc. Announces Pricing of Add-On Notes OfferingGlobeNewswire Inc. AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the BoardGlobeNewswire Inc. Why Surgery Partners Stock Plummeted on MondayThe Motley Fool Surgery Partners, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call DetailsGlobeNewswire Inc. Surgery Partners (SGRY) Q2 Revenue Up 8%The Motley Fool
Show 12 more stories
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call DetailsGlobeNewswire Inc. Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain CapitalBenzinga After-hours movers: Netflix, Intuitive Surgical, and more By Investing.com - Investing.com CanadaInvesting.com Critical Insights From Surgery Partners Analyst Ratings: What You Need To KnowBenzinga Teladoc (TDOC) Soars 6.7%: Is Further Upside Left in the Stock?Zacks Investment Research Surgery Partners (SGRY) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research DocGo Inc. (DCGO) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research Earnings Preview: Surgery Partners (SGRY) Q1 Earnings Expected to DeclineZacks Investment Research Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call DetailsGlobeNewswire Inc. SGRY vs. DOCS: Which Stock Should Value Investors Buy Now?Zacks Investment Research Surgery Partners, Inc. Announces Pricing of New Senior Notes OfferingGlobeNewswire Inc. Surgery Partners, Inc. Announces New Senior Notes OfferingGlobeNewswire Inc.
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
Discover more
You may be interested in